ConductScience.org, home

Paper40501468

Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury.

Ramírez-Mejía MM and 2 others. World J Hepatol, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury. Papers, record 40501468. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40501468

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury.
PubMed
Journal
World J Hepatol
PubMed
Year
2025
PubMed
Publication types
Letter
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-06-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ramírez-Mejía MMMariana M
2Teschke RRolf
3Méndez-Sánchez NNahum

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121349301Causality assessment methods in drug induced liver injury: strengths and weaknesses.J Hepatol2011https://conductscience.org/library/papers/21349301PubMed
240027577Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver.World J Hepatol2025https://conductscience.org/library/papers/40027577PubMed
38229110Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.J Clin Epidemiol1993https://conductscience.org/library/papers/8229110PubMed
438049180Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).J Obes Metab Syndr2023https://conductscience.org/library/papers/38049180PubMed
531417407Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future.Front Pharmacol2019https://conductscience.org/library/papers/31417407PubMed
636569882Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis.Front Immunol2022https://conductscience.org/library/papers/36569882PubMed
78229111Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.J Clin Epidemiol1993https://conductscience.org/library/papers/8229111PubMed
838287834Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.Front Biosci (Landmark Ed)2024https://conductscience.org/library/papers/38287834PubMed
933003400Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.Medicines (Basel)2020https://conductscience.org/library/papers/33003400PubMed
1039166347Methods for causality assessment of idiosyncratic drug-induced liver injury.Liver Int2025https://conductscience.org/library/papers/39166347PubMed
1128405790CSH guidelines for the diagnosis and treatment of drug-induced liver injury.Hepatol Int2017https://conductscience.org/library/papers/28405790PubMed
1236968618Drug-induced liver injury: a comprehensive review.Ther Adv Gastroenterol2023https://conductscience.org/library/papers/36968618PubMed
1335603224Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease.Front Immunol2022https://conductscience.org/library/papers/35603224PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40501468

GET https://conductscience.org/api/papers/v1/40501468/authors